Christine Coyne

Christine Coyne is a global executive with a consistent track record of bringing molecules from clinical development to market successfully. She is highly skilled at building performance-driven teams, developing brand and organizational strategy and operationalizing plans to drive growth consistently. She has successfully managed businesses with P&Ls between $25M – $200M. Christine has a broad disease state background including hospital, rare disease, orphan conditions, vaccines, antibiotics, oncology, autoimmune diseases and pain. She is an excellent communicator who is facile at leading teams through changes while achieving commercial goals.